Many fixed dose drug combinations for sale in India are not approved

Large numbers of fixed dose drug combinations—formulations that contain two or more active compounds in a fixed ratio of doses—are being sold to patients in India without having been approved by central regulatory authorities for safety and efficacy, research published this week in PLOS Medicine ...